Access cutting-edge acute kidney injury treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Detroit location
Preparing your pre-screening questions…
Access acute kidney injury specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute kidney injury treatment provided free
Check if you qualify for this acute kidney injury clinical trial in Detroit, MI
No-Cost Study Care
Local to Detroit
Convenient for MI residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
A prospective, randomized, placebo-controlled clinical study to investigate the safety and efficacy of Niyad (nafamostat mesylate) for anticoagulation of extracorporeal blood circulating through a dialysis filter in patients undergoing CRRT who cannot tolerate heparin or are at higher risk for bleeding.
Sponsor: Talphera, Inc
Yes, this clinical trial (NCT06150742) has an active research site in Detroit, MI that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for acute kidney injury treatment options in Detroit, MI, this clinical trial (NCT06150742) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute kidney injury specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.